LENZ Therapeutics (LENZ) Enterprise Value (2022 - 2023)
Historic Enterprise Value for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to -$234.0 million.
- Therapeutics' Enterprise Value rose 1978.13% to -$234.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$234.0 million, marking a year-over-year increase of 1978.13%. This contributed to the annual value of -$268.2 million for FY2022, which is N/A changed from last year.
- According to the latest figures from Q3 2023, Therapeutics' Enterprise Value is -$234.0 million, which was up 1978.13% from -$246.7 million recorded in Q2 2023.
- In the past 5 years, Therapeutics' Enterprise Value ranged from a high of -$202.2 million in Q1 2023 and a low of -$339.2 million during Q1 2022